["{\n\"step_by_step_thinking\": \"Based on the information provided, we know that drug X is used to reduce the action of testosterone by blocking the androgen receptor. This suggests that it is a type of antiandrogen medication. We also know that the patient has no significant complaints, except for excessive sweating at times, which could be related to the medication's mechanism of action. Additionally, we are given information about prostate cancer treatment options, including hormonal therapy and chemotherapy.\n\nLooking at the potential choices, A: Leuprolide is an LHRH agonist, which means it can cause castration levels of testosterone, but it does not specifically block the androgen receptor. B: Finasteride is a 5-alpha reductase inhibitor, which inhibits the conversion of testosterone to dihydrotestosterone (DHT), but it does not directly affect the androgen receptor.\n\nC: Flutamide is an antiandrogen medication that binds to the androgen receptor, blocking its action. This makes it the most likely candidate to be in the same class as drug X.\n\nD: Anastrozole is a selective estrogen receptor modulator (SERM), which means it affects estrogen receptors rather than androgen receptors.\n\nTherefore, based on the information provided, the most likely answer is C: Flutamide.\",\n\"answer_choice\": \"C\""]